C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/445 (2006.01) A61K 31/454 (2006.01) A61P 3/04 (2006.01) A61P 25/00 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2558058
Compounds of formula I, processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders and to pharmaceutical compositions containing them.
La présente invention concerne des composés représentés par la formule I, des procédés permettant de préparer de tels composés, leur utilisation dans le traitement de l'obésité, des troubles psychiatriques, des troubles cognitifs, des troubles de la mémoire, de la schizophrénie, de l'épilepsie et de troubles associés, ainsi que des troubles neurologiques, tels que la démence, la sclérose en plaques, la maladie de Parkinson, la chorée de Huntington et la maladie d'Alzheimer et la douleur associée à ces troubles. Cette invention concerne également des compositions pharmaceutiques contenant de tels composés.
Brickmann Kay
Egner Bryan J.
Giordanetto Fabrizio
Inghardt Tord
Linusson Jonsson Anna
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
N-piperidine derivates as ccr3 modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-piperidine derivates as ccr3 modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-piperidine derivates as ccr3 modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1377269